News Release 2020

• November 27, 2020

  Kyorin Pharmaceutical Receives Marketing Approval for injectable New Quinolone Antibacterial Agent "Lasvic® Intravenous Drip Infusion Kit 150mg"

• October 12, 2020

  KYORIN assigns Intellectual Properties regarding KRP-203 to Priothera

• September 30, 2020

  Notice regarding the joint development and commercialization agreement for [AKP-009], a treatment agent for Benign Prostatic Hyperplasia

• August 3, 2020

  KYORIN and Otonomy Signed License Agreement for Novel Candidate Compound for Sensorineural Hearing Loss

• June 29, 2020

  Kyorin Pharmaceutical obtains approval for additional indication for pediatric use of Flutiform® 50 Aerosol, a combination drug for asthma treatment

• March 31, 2020

  Release of Novel Coronavirus Detection Reagent "SARS-CoV-2 GeneSoC ER Kyorin"

• January 6, 2020

  KYORIN and aTyr to Collaborate on Novel Immunomodulator

• 1